Art

J-GLOBAL ID：202302215853371495   Reference number：23A0601335

Clinical Management of COVID-19: A Review of Pharmacological Treatment Options

COVID-19の臨床管理: 薬理学的治療選択肢のレビュー【JST・京大機械翻訳】

Author (4)： Heustess Ashli M. (School of Pharmacy, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC 27501, USA) ,  Allard Melissa A. (School of Pharmacy, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC 27501, USA) ,  Thompson Dorothea K. (Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC 27501, USA) ,  Fasinu Pius S. (Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Campbell University, Buies Creek, NC 27501, USA)
Material： Pharmaceuticals (Web)
Volume： 14  Issue： 6  Page： 520  Publication year： 2021 
JST Material Number： U7257A  ISSN： 1424-8247  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Since the outbreak and subsequ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=23A0601335&from=J-GLOBAL&jstjournalNo=U7257A") }}

Thesaurus term： safety ,  database ,  plasma(blood) ,  interferon ,  immunoglobulin ,  adrenocortical hormone ,  drug ,  vaccine ,  *drug therapy ,  public health ,  *pharmacology ,  *therapy ,  nitrogen heterocyclic compound ,  aromatic chlorine compound ,  polynuclear aromatic compound ,  diamine ,  tertiary amine ,  secondary amine ,  aminoalcohol
Semi thesaurus term： トシリズマブ , 【Automatic Indexing@JST】

Author keywords (6)： COVID-19 ,  SARS-CoV-2 ,  antivirals ,  casirivimab/imdevimab ,  convalescent plasma ,  remdesivir

JST classification (1)： Infectious diseases,parasitics diseases in general.  (GD01010H)

Substance index (2)： Chloroquine ,  Hydroxychloroquine

Reference (182)：

• WHO. Director-General’s Opening Remarks at the Media Briefing on COVID19. Available online: https://www.who.int/news/item/27-04-2020-who-timeline---covid-19 (accessed on 24 May 2021). WHO. COVID-19 Dashboard. Available online: https://covid19.who.int/ (accessed on 5 May 2021).
• Guarner, J. Three emerging coronaviruses in two decades: The story of SARS, MERS, and now COVID-19. Am. J. Clin. Pathol. 2020, 153, 420-421.
• Goldsmith, C.S.; Tatti, K.M.; Ksiazek, T.G.; Rollin, P.E.; Comer, J.A.; Lee, W.W.; Rota, P.A.; Bankamp, B.; Bellini, W.J.; Zaki, S.R. Ultrastructural characterization of SARS coronavirus. Emerg. Infect. Dis. 2004, 10, 320-326.
• Chen, Y.; Liu, Q.; Guo, D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol. 2020, 92, 418-423.
• Chan, J.F.W.; Yuan, S.; Kok, K.H.; To, K.K.W.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C.C.; Poon, R.W.; et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet 2020, 395, 514-523.

Terms in the title (4)： 臨床管理 ,  薬理学的治療 ,  選択肢 ,  レビュー